“EFFICACY OF NIVOLUMAB (NWO) DURING 2+ LINE TREATMENT AND QUALITY OF LIFE IN PATIENTS WITH ADVANCED REFRACTORY NON-SMALL CELL LUNG CANCER: INTERIM RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY”, Вопр. онкол., vol. 65, no. 1, pp. 99–105, Jan. 2019, doi: 10.37469/0507-3758-2019-65-1-99-105.